-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Cognition Therapeutics Inc annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2021 to 2023.
- Cognition Therapeutics Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2022 was -$125K.
- Cognition Therapeutics Inc annual Income Tax Expense (Benefit) for 2023 was $0.000.
- Cognition Therapeutics Inc annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Annual (USD)